Latvia vs Türkiye: Hepatitis B surface antigen (HBsAg) prevalence
Latvia
0.0%
in 2024
Türkiye
0.0%
in 2024
Latvia rank
132nd
Türkiye rank
132nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Latvia
- Türkiye
How they compare
Latvia currently reports 0.0% against 0.0% in Türkiye, a difference of 0.0%.
Across all 10 years both countries report, Türkiye has been ahead every year.
Latvia ranks 132nd and Türkiye ranks 132nd of 194 countries.
Türkiye has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Latvia | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.0% | Türkiye |
| 2020s | 0.0% | 0.1% | 0.1% | Türkiye |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Latvia or Türkiye?
- Latvia, at 0.0% against 0.0% in Türkiye as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Latvia and Türkiye?
- 0.0%, with Latvia ahead.
- How many years of comparable data are there for Latvia and Türkiye?
- 10 years are reported by both, from 2015 to 2024.
- How do Latvia and Türkiye rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Latvia ranks 132nd and Türkiye ranks 132nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.